Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor (NCT03599765)
External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease
🩺 Plain-English Summary (8th-Grade Level)
This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body. Treatment with up-front local consolidative therapy may be better in helping to control the disease.
Who can join: Review the eligibility criteria below.
Location: Banner MD Anderson Cancer Center — Gilbert, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- Best Practice (OTHER)
- Local Consolidation Therapy (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- Banner MD Anderson Cancer Center — Gilbert, Arizona
- Baptist Health Medical Center — Little Rock, Arkansas
- Queen's Medical Center — Honolulu, Hawaii
- Community Health Center — Coldwater, Michigan
- Cooper Hospital University Medical Center — Camden, New Jersey
- OhioHealth Mansfield Hospital — Mansfield, Ohio
- M D Anderson Cancer Center — Houston, Texas
- MD Anderson in Katy — Houston, Texas
- MD Anderson League City — Nassau Bay, Texas
- University of Texas Health Science Center at San Antonio — San Antonio, Texas
- MD Anderson in Sugar Land — Sugar Land, Texas
- MD Anderson in The Woodlands — The Woodlands, Texas
📞 Contact the Study Coordinator
Phone: (877) 632-6789
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Oligometastatic Malignant Solid Neoplasm
- Total RadIoTherapy of Oligometastatic caNcerS — La Jolla, California
Explore by condition: All Oligometastatic Malignant Solid Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.